An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment.
Tekpli X, Lien T, Røssevold AH, Nebdal D, Borgen E, Ohnstad HO, Kyte JA, Vallon-Christersson J, Fongaard M, Due EU, Svartdal LG, Sveli MAT, Garred Ø; OSBREAC; Frigessi A, Sahlberg KK, Sørlie T, Russnes HG, Naume B, Kristensen VN.
Tekpli X, et al. Among authors: ohnstad ho.
Nat Commun. 2019 Dec 3;10(1):5499. doi: 10.1038/s41467-019-13329-5.
Nat Commun. 2019.
PMID: 31796750
Free PMC article.